151 related articles for article (PubMed ID: 17250952)
1. Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis.
Mazzuco TL; Chabre O; Feige JJ; Thomas M
Mol Cell Endocrinol; 2007 Feb; 265-266():23-8. PubMed ID: 17250952
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features.
Mazzuco TL; Chabre O; Feige JJ; Thomas M
J Clin Endocrinol Metab; 2006 Jan; 91(1):196-203. PubMed ID: 16249277
[TBL] [Abstract][Full Text] [Related]
3. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model.
Mazzuco TL; Chabre O; Sturm N; Feige JJ; Thomas M
Endocrinology; 2006 Feb; 147(2):782-90. PubMed ID: 16254030
[TBL] [Abstract][Full Text] [Related]
4. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction.
Lacroix A; Bourdeau I; Lampron A; Mazzuco TL; Tremblay J; Hamet P
Clin Endocrinol (Oxf); 2010 Jul; 73(1):1-15. PubMed ID: 19719763
[TBL] [Abstract][Full Text] [Related]
5. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators.
Bourdeau I; Antonini SR; Lacroix A; Kirschner LS; Matyakhina L; Lorang D; Libutti SK; Stratakis CA
Oncogene; 2004 Feb; 23(8):1575-85. PubMed ID: 14767469
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
Louiset E; Isvi K; Gasc JM; Duparc C; Cauliez B; Laquerrière A; Kuhn JM; Lefebvre H
Endocr Relat Cancer; 2008 Dec; 15(4):1025-34. PubMed ID: 18708508
[TBL] [Abstract][Full Text] [Related]
7. Adrenocorticotropic hormone-independent Cushing's syndrome.
Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
[TBL] [Abstract][Full Text] [Related]
8. Is the adrenal cortex a target for gonadotropins?
Bernichtein S; Alevizaki M; Huhtaniemi I
Trends Endocrinol Metab; 2008 Sep; 19(7):231-8. PubMed ID: 18691899
[TBL] [Abstract][Full Text] [Related]
9. Cushing's syndrome variants secondary to aberrant hormone receptors.
Lacroix A; Baldacchino V; Bourdeau I; Hamet P; Tremblay J
Trends Endocrinol Metab; 2004 Oct; 15(8):375-82. PubMed ID: 15380809
[TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism.
Ye P; Mariniello B; Mantero F; Shibata H; Rainey WE
J Endocrinol; 2007 Oct; 195(1):39-48. PubMed ID: 17911395
[TBL] [Abstract][Full Text] [Related]
11. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation.
Matyakhina L; Freedman RJ; Bourdeau I; Wei MH; Stergiopoulos SG; Chidakel A; Walther M; Abu-Asab M; Tsokos M; Keil M; Toro J; Linehan WM; Stratakis CA
J Clin Endocrinol Metab; 2005 Jun; 90(6):3773-9. PubMed ID: 15741255
[TBL] [Abstract][Full Text] [Related]
12. Aberrant hormone receptors in primary aldosteronism.
Mazzuco TL; Grunenwald S; Lampron A; Bourdeau I; Lacroix A
Horm Metab Res; 2010 Jun; 42(6):416-23. PubMed ID: 20503136
[TBL] [Abstract][Full Text] [Related]
13. Expression of prepro-ghrelin and related receptor genes in the rat adrenal gland and evidences that ghrelin exerts a potent stimulating effect on corticosterone secretion by cultured rat adrenocortical cells.
Rucinski M; Ziolkowska A; Tyczewska M; Malendowicz LK
Peptides; 2009 Aug; 30(8):1448-55. PubMed ID: 19416745
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical tumorigenesis.
Beuschlein F; Reincke M
Ann N Y Acad Sci; 2006 Nov; 1088():319-34. PubMed ID: 17192577
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6.
Vuorenoja S; Rivero-Muller A; Kiiveri S; Bielinska M; Heikinheimo M; Wilson DB; Huhtaniemi IT; Rahman NA
Mol Cell Endocrinol; 2007 Apr; 269(1-2):38-45. PubMed ID: 17337116
[TBL] [Abstract][Full Text] [Related]
16. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
Stratakis CA; Boikos SA
Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):748-57. PubMed ID: 17955016
[TBL] [Abstract][Full Text] [Related]
17. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates.
Louiset E; Contesse V; Groussin L; Cartier D; Duparc C; Perraudin V; Bertherat J; Lefebvre H
J Endocrinol; 2008 Jan; 196(1):1-9. PubMed ID: 18180312
[TBL] [Abstract][Full Text] [Related]
18. [Telomerase expression in various lesions of adrenal cortex].
Mao QZ; Rong S; Fan JH; Ji ZG; Li HZ; Zang MF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):188-9. PubMed ID: 12905801
[TBL] [Abstract][Full Text] [Related]
19. Adrenal hyperplasia and tumours in mice in connection with aberrant pituitary-gonadal function.
Bernichtein S; Peltoketo H; Huhtaniemi I
Mol Cell Endocrinol; 2009 Mar; 300(1-2):164-8. PubMed ID: 19007852
[TBL] [Abstract][Full Text] [Related]
20. Insights into the role of genetic alterations in adrenocortical tumorigenesis.
Herbet M; Feige JJ; Thomas M
Mol Cell Endocrinol; 2009 Mar; 300(1-2):169-74. PubMed ID: 19007854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
